Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Alabama at Birmingham
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Biopsy-proven treatment-naïve prostate adenocarcinoma with pelvic metastases known to suspected on standard-of-care staging imaging
Eligibility and plan to undergo definitive radiation therapy for prostate cancer per established standard-of-care radiation oncology clinical guidelines
Be at least 18 years of age
You may not be if
Inability to tolerate or undergo PET/MRI or PET/CT
Previous or current hematologic or lymphatic disorder (including leukemia, lymphoma, Castleman's disease, etc.)
Recurrent prostate adenocarcinoma
Known distant metastatic disease
Current or prior treatment for prostate cancer
Known allergy to glucagon
Previous diagnosis of insulinoma or pheochromocytoma
Clareo Health | PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study
